Research programme: protein arginine methyltransferase 5 / methylthioadenosine - Schrodinger
Alternative Names: Research programme: PRMT5-MTA - SchrodingerLatest Information Update: 11 Nov 2023
At a glance
- Originator Schrodinger
- Class Antineoplastics
- Mechanism of Action PRMT5 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Haematological malignancies; Solid tumours